4//SEC Filing
BLAIR JAMES C 4
Accession 0000904454-19-000331
CIK 0001466301other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:53 PM ET
Size
10.7 KB
Accession
0000904454-19-000331
Insider Transaction Report
Form 4
BLAIR JAMES C
Director10% Owner
Transactions
- Other
Common Stock
2019-03-18+701→ 10,105 total(indirect: By Susan W. and James C. Blair Family L.P.) - Sale
Common Stock
2019-03-14$27.79/sh−17,056$473,986→ 0 total(indirect: By DP VII Associates, L.P.) - Other
Common Stock
2019-03-18−10,000→ 0 total(indirect: By LLC) - Other
Common Stock
2019-03-18+522→ 13,439 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.67 to $27.94. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The Reporting Person is a managing member of One Palmer Square Associates VII, LLC, the sole general partner of DP VII Associates, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities owned by each such entity, however he disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or that are not actually distributed to him.
- [F3]Distribution-in-kind of shares by One Palmer Square Associates VII, LLC, pro rata to its members.
- [F4]The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
Documents
Issuer
Clovis Oncology, Inc.
CIK 0001466301
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001024000
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 4:53 PM ET
- Size
- 10.7 KB